Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Prize winner
Case
-
Reference no. 9-210-040
Published by: Harvard Business Publishing
Originally published in: 2011
Version: 28 September 2011
Revision date: 9-Nov-2011
Length: 32 pages
Data source: Field research

Abstract

Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and cons of merging the two companies with different cultures, the value of Genentech, and the tactics of a hostile tender offer.

Teaching and learning

This item is suitable for executive education courses.

Time period

The events covered by this case took place in 2008-2009.

Geographical setting

Region:
World/global
Countries:
Switzerland; United States

Featured companies

Roche Group
Industry:
Biotechnology; Pharmaceuticals
Genentech
Industry:
Biotechnology; Pharmaceuticals

Featured protagonist

  • Franz Humer (male), CEO

About

Abstract

Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and cons of merging the two companies with different cultures, the value of Genentech, and the tactics of a hostile tender offer.

Teaching and learning

This item is suitable for executive education courses.

Settings

Time period

The events covered by this case took place in 2008-2009.

Geographical setting

Region:
World/global
Countries:
Switzerland; United States

Featured companies

Roche Group
Industry:
Biotechnology; Pharmaceuticals
Genentech
Industry:
Biotechnology; Pharmaceuticals

Featured protagonist

  • Franz Humer (male), CEO

Related


Awards, prizes & competitions